Authors


Joel S. Weissman, PhD

Latest:

Geographic Variation in Medicare and the Military Healthcare System

Geographic variation in healthcare spending and utilization within the Military Health System is higher and significantly correlated with Medicare across hospital referral regions.




managed care, healthcare, cancer, melanoma, hospice, ipilimumab, vemurafenib, metastatic, survival rates, end-of-life, healthcare costs, Affordable Care Act, patient-centered, palliative care

Latest:

More Hospice Care Meant Longer Survival, Lower End-of-Life Costs for Metastatic Melanoma Patients

A study in The American Journal of Managed Care found that longer stays in hospice were associated with longer survival and lower end-of-life costs for patients with metastatic melanoma, a particularly deadly and increasingly common form of cancer.





John Trombley II, MPP

Latest:

Emergency Department Use: A Reflection of Poor Primary Care Access?

An original emergency department patient survey, insurance claims data, and administrative records are used to examine the characteristics of nonurgent users.


Jeffrey A. Linder, MD, MPH

Latest:

Antibiotic Prescribing for Respiratory Infections at Retail Clinics, Physician Practices, and Emergency Departments

There are concerns that retail clinics provide inferior quality of care. The authors found no difference in quality among retail clinics, physician offices, and emergency departments.



Richard Zeckhauser, PhD

Latest:

Medicare Advantage: What Explains Its Robust Health?

Payment policy, health plan characteristics, and Medicare beneficiary characteristics come together to foster continued growth in the Medicare Advantage program.


Stephen Stemkowski, PhD

Latest:

Initiation of Triple Therapy Maintenance Treatment Among Patients With COPD

Claims data analysis showed that 60% of patients with chronic obstructive pulmonary disease (COPD) receiving triple therapy had no evidence of exacerbation or only 1 exacerbation not resulting in hospitalization.


John A. Romley, PhD

Latest:

Quantifying the Insurance Value for Rare Diseases: Duchenne Muscular Dystrophy

The degree to which novel value elements such as insurance value impact estimated treatment value for rare, severe genetic diseases such as Duchenne muscular dystrophy is unclear.




Dennis Schaberg, MD

Latest:

Evaluation of Human Immunodeficiency Virus and Hepatitis C Telemedicine Clinics

In an integrated health system, human immunodeficiency virus and hepatitis C telemedicine clinics are associated with improved access, high patient satisfaction, and reduction in health visit“related time.



James S. Goodwin, MD

Latest:

The Combined Effect of the Electronic Health Record and Hospitalist Care on Length of Stay

No national studies have examined the interaction effect of the electronic health record (EHR) and hospitalist care on length of stay (LOS). Thus, we examine the combined effect of the EHR and hospitalist care on LOS.


Neda Ratanawongsa, MD, MPH

Latest:

Patient Factors Associated With Following a Relocated Primary Care Provider Among Older Adults

There are differences between patients who elect to maintain continuity with their PCP versus those who choose to change their PCP for convenience.


Andrew Delgado, PharmD

Latest:

The Value of Novel Immuno-Oncology Treatments

This study assesses the value of novel immuno-oncology treatments to society.


Piri L. Welcsh, PhD

Latest:

The Impact of Germline Testing for Hereditary Cancer Postdiagnosis

Authors from Facing Our Risk of Cancer Empowered (FORCE), a nonprofit organization focused on hereditary cancer, discuss the importance of genetic testing, guidelines, and coverage considerations.



Byron Bair, MD

Latest:

Review of Veterans Health Administration Telemedicine Interventions

A review of exemplary VHA-sponsored telemedicine interventions indicates that telemedicine can efficiently address patient healthcare needs.


James M. Eudicone, MS, MBA

Latest:

Authors’ Reply to “Comment on Generalizability of GLP-1 RA CVOTs in US T2D Population”

The authors of the manuscript “Generalizability of Glucagon-Like Peptide-1 Receptor Agonist Cardiovascular Outcome Trials Enrollment Criteria to the US Type 2 Diabetes Population” respond to a letter to the editor.


Harold A. Pincus, MD

Latest:

Strategies for Identifying and Channeling Patients for Depression Care Management

This article examines screening strategies for possible depression in the context of a care management program for chronically ill Medicare recipients.


Chadi Nabhan, MD, MBA

Latest:

The Gamification of Healthcare: Emergence of the Digital Practitioner?

Gamification in healthcare is gaining momentum, with attempts to apply gaming principles to improve patient clinical outcomes. This trend establishes the need for a “digital practitioner” who channels these games, monitors progress, and selects the most appropriate ones for a given patient.



James N. Ciriello, MS

Latest:

Smart Health Community: The Hidden Value of Health Information Exchange

Smart Health Communities create new value by leveraging investments in health information exchange to provide an array of services for both consumer and community.



John F. Bresnahan, MD

Latest:

Clinical and Economic Outcomes After Introduction of Drug-Eluting Stents

Introduction of drug-eluting stents resulted in improved clinical outcomes for patients and reduced overall procedural costs.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo